SCHEMBL13628864

SCHEMBL13628864

COOSc1cnc2c(c1)cc(-c1ncncc1F)n2Cc1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 17/20 0.39
CYP3A4 P08684 16/20 0.39
USP2 O75604 13/20 0.39
CYP2C9 P11712 11/20 0.39
CYP2C19 P33261 11/20 0.39
MAPK1 P28482 8/20 0.39
TSHR P16473 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
ALDH1A1 P00352 6/20 0.39
ALOX15 P16050 2/20 0.39
HIF1A Q16665 2/20 0.39
LMNA P02545 4/20 0.38
HPGD P15428 1/20 0.37
CYP2D6 P10635 3/20 0.37
CASP1 P29466 3/20 0.37
CASP7 P55210 3/20 0.37
HSD17B10 Q99714 1/20 0.35
CNR1 P21554 2/20 0.34
CNR2 P34972 2/20 0.34
HBB P68871 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13628825 0.82 CYP1A2 (0.37) CYP1A2CYP3A4USP2CYP2C9CYP2C19
SCHEMBL13628831 0.80 MCL1 (0.39) CYP1A2CYP3A4USP2CYP2C9CYP2C19
SCHEMBL13628822 0.79 CYP1A2 (0.37) CYP1A2CYP3A4USP2CYP2C9CYP2C19
SCHEMBL13628838 0.79 CYP1A2 (0.36) CYP1A2CYP3A4USP2CYP2C9CYP2C19
SCHEMBL13628819 0.79 CNR1 (0.43) CYP1A2CYP3A4USP2CYP2C9CYP2C19
SCHEMBL2925653 0.78 CYP1A2 (0.43) CYP1A2CYP3A4USP2CYP2C9CYP2C19
SCHEMBL13628861 0.78 RAB9A (0.38) CYP1A2CYP3A4USP2CYP2C9CYP2C19
SCHEMBL13628855 0.77 CYP1A2 (0.33) CYP1A2CYP3A4USP2CYP2C9CYP2C19
SCHEMBL13628856 0.74 CNR2 (0.40) LMNACNR1CNR2
SCHEMBL13628865 0.69 RAB9A (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612070-B2 Heterocyclic compounds as antiinflammatory agents and cyclooxygenase inhibitors CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2009-11-03 US disclosed